Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2006;99:510-519
Published online before print July 27, 2006, doi: 10.1161/01.RES.0000238359.18495.42
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
99/5/510    most recent
01.RES.0000238359.18495.42v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Barnes, K.
Right arrow Articles by Baldwin, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Barnes, K.
Right arrow Articles by Baldwin, S. A.
Related Collections
Right arrow Biochemistry and metabolism
Right arrow Cell biology/structural biology
Right arrow Ischemic biology - basic studies
Right arrow Ion channels/membrane transport
(Circulation Research. 2006;99:510.)
© 2006 American Heart Association, Inc.


Cellular Biology

Distribution and Functional Characterization of Equilibrative Nucleoside Transporter-4, a Novel Cardiac Adenosine Transporter Activated at Acidic pH

Kay Barnes, Halina Dobrzynski*, Sophie Foppolo*, Paul R. Beal*, Fouzia Ismat, Elspeth R. Scullion, Lijie Sun, James Tellez, Mabel W.L. Ritzel, William C. Claycomb, Carol E. Cass, James D. Young, Rudi Billeter-Clark, Mark R. Boyett, Stephen A. Baldwin

From the Institute of Membrane and Systems Biology (K.B., S.F., P.R.B., F.I., E.R.S., L.S., R.B.-C., S.A.B.), University of Leeds, UK; Division of Cardiovascular and Endocrine Sciences (H.D., J.T., M.R.B.), University of Manchester, UK; Membrane Protein Research Group (M.W.L.R., C.E.C., J.D.Y.) and Departments of Physiology (M.W.L.R., J.D.Y.) and Oncology (C.E.C.), University of Alberta, and Cross Cancer Institute (C.E.C.), Edmonton, Alberta, Canada; and Department of Biochemistry and Molecular Biology (W.C.C.), Louisiana State, University Health Sciences Center, New Orleans. Current address for P.R.B.: Department of Biology, University of York, UK.

Correspondence to Kay Barnes, Institute of Membrane and Systems Biology, University of Leeds, Leeds LS2 9JT, UK. E-mail K.Barnes{at}leeds.ac.uk

Adenosine plays multiple roles in the efficient functioning of the heart by regulating coronary blood flow, cardiac pacemaking, and contractility. Previous studies have implicated the equilibrative nucleoside transporter family member equilibrative nucleoside transporter-1 (ENT1) in the regulation of cardiac adenosine levels. We report here that a second member of this family, ENT4, is also abundant in the heart, in particular in the plasma membranes of ventricular myocytes and vascular endothelial cells but, unlike ENT1, is virtually absent from the sinoatrial and atrioventricular nodes. Originally described as a monoamine/organic cation transporter, we found that both human and mouse ENT4 exhibited a novel, pH-dependent adenosine transport activity optimal at acidic pH (apparent Km values 0.78 and 0.13 mmol/L, respectively, at pH 5.5) and absent at pH 7.4. In contrast, serotonin transport by ENT4 was relatively insensitive to pH. ENT4-mediated nucleoside transport was adenosine selective, sodium independent and only weakly inhibited by the classical inhibitors of equilibrative nucleoside transport, dipyridamole, dilazep, and nitrobenzylthioinosine. We hypothesize that ENT4, in addition to playing roles in cardiac serotonin transport, contributes to the regulation of extracellular adenosine concentrations, in particular under the acidotic conditions associated with ischemia.


Key Words: nucleoside • adenosine • transport • ischemia • pH




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. M. Hoque, L. Chen, G. P. H. Leung, and C.-M. Tse
A purine-selective nucleobase/nucleoside transporter in PK15NTD cells
Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2008; 294(6): R1988 - R1995.
[Abstract] [Full Text] [PDF]


Home page
Exp PhysiolHome page
I. Markovic, M. Segal, B. Djuricic, and Z. Redzic
Kinetics of nucleoside uptake by the basolateral side of the sheep choroid plexus epithelium perfused in situ
Exp Physiol, March 1, 2008; 93(3): 325 - 333.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
J. B. Rose and I. R. Coe
Physiology of Nucleoside Transporters: Back to the Future. . . .
Physiology, February 1, 2008; 23(1): 41 - 48.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. Govindarajan, A. H. Bakken, K. L. Hudkins, Y. Lai, F. J. Casado, M. Pastor-Anglada, C.-M. Tse, J. Hayashi, and J. D. Unadkat
In situ hybridization and immunolocalization of concentrative and equilibrative nucleoside transporters in the human intestine, liver, kidneys, and placenta
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2007; 293(5): R1809 - R1822.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
M. Zhou, L. Xia, and J. Wang
Metformin Transport by a Newly Cloned Proton-Stimulated Organic Cation Transporter (Plasma Membrane Monoamine Transporter) Expressed in Human Intestine
Drug Metab. Dispos., October 1, 2007; 35(10): 1956 - 1962.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
V. L. Damaraju, A. N. Elwi, C. Hunter, P. Carpenter, C. Santos, G. M. Barron, X. Sun, S. A. Baldwin, J. D. Young, J. R. Mackey, et al.
Localization of broadly selective equilibrative and concentrative nucleoside transporters, hENT1 and hCNT3, in human kidney
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F200 - F211.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
F. Visser, L. Sun, V. Damaraju, T. Tackaberry, Y. Peng, M. J. Robins, S. A. Baldwin, J. D. Young, and C. E. Cass
Residues 334 and 338 in Transmembrane Segment 8 of Human Equilibrative Nucleoside Transporter 1 Are Important Determinants of Inhibitor Sensitivity, Protein Folding, and Catalytic Turnover
J. Biol. Chem., May 11, 2007; 282(19): 14148 - 14157.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. Loffler, J. C. Morote-Garcia, S. A. Eltzschig, I. R. Coe, and H. K. Eltzschig
Physiological Roles of Vascular Nucleoside Transporters
Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1004 - 1013.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Zhou, L. Xia, K. Engel, and J. Wang
Molecular Determinants of Substrate Selectivity of a Novel Organic Cation Transporter (PMAT) in the SLC29 Family
J. Biol. Chem., February 2, 2007; 282(5): 3188 - 3195.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. K. Bubien and D. J. Benos
Molecular pH Probes: Mediators of Angina and Ischemic Preconditioning?
Circ. Res., September 1, 2006; 99(5): 453 - 454.
[Full Text] [PDF]